Status:
COMPLETED
Corneal Epithelial Stem Cells and Dry Eye Disease
Lead Sponsor:
Sloan W. Rush, MD
Conditions:
Dry Eye Syndromes
Dry Eye
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot stud...
Detailed Description
Eligible patients presenting with severe dry eye disease that have failed treatment with conventional measures will be screened for inclusion into the study. The treatment will consist of administrati...
Eligibility Criteria
Inclusion
- Clinical diagnosis of advanced dry eye disease
- Severe dry eye symptoms despite having tried over a half dozen treatments
Exclusion
- Not willing to undergo clinical trial
- Unable to comply with treatment regimen
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT03302273
Start Date
February 1 2019
End Date
April 1 2022
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush Eye Associates
Amarillo, Texas, United States, 79109